Verrica Pharmaceuticals I... (VRCA)
NASDAQ: VRCA
· Real-Time Price · USD
6.02
-0.13 (-2.11%)
At close: Aug 15, 2025, 2:03 PM
Verrica Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -48.6M | -65.99M | -76.58M | -84.99M | -86.93M | -80.74M | -67M | -48.31M | -23.43M | -22.61M | -24.49M | -28.09M | -41.01M | -42.61M | -35.08M | -38.52M | -36.17M | -33.81M |
Depreciation & Amortization | 921K | 1.14M | 1.27M | 1.23M | 1.24M | 1.04M | 907K | 1.08M | 859K | 822K | 718K | 693K | 677K | 616K | 529K | 357K | 251K | 226K |
Stock-Based Compensation | 4.78M | 6.12M | 7.16M | 8.48M | 16.04M | 15.35M | 14.38M | 13.47M | 5.22M | 4.76M | 4.99M | 5.13M | 5.2M | 5.97M | 6.05M | 11.07M | 10.82M | 10.23M |
Other Working Capital | -3.29M | -915K | -1.74M | 7.76M | 10.35M | 11.83M | 11.47M | 6.05M | 2.25M | 376K | -1.26M | -1.54M | -1.08M | 9.81M | -1.03M | 7K | 2.32M | -10.7M |
Other Non-Cash Items | 4.82M | 5.13M | 5.19M | 7.29M | 5.23M | 3.98M | 3.5M | -1.99M | -1.01M | -2K | 407K | 940K | 1.54M | 1.46M | 1.44M | 1.42M | 1.34M | 1.27M |
Deferred Income Tax | n/a | n/a | n/a | -2.15M | -666K | n/a | n/a | 2.15M | 666K | n/a | n/a | -118K | -22K | 24K | 66K | 41K | -40K | -69K |
Change in Working Capital | -9.26M | -48K | 2.03M | 10.76M | -540K | 6.42M | 9.63M | 4.58M | 3.78M | 596K | -1.8M | -2.48M | -1.15M | 9.47M | -535K | 697K | 1.81M | -10.93M |
Operating Cash Flow | -47.34M | -53.66M | -60.93M | -59.37M | -65.62M | -53.93M | -38.58M | -29.02M | -12.39M | -14.9M | -18.65M | -22.39M | -34.82M | -25.14M | -27.58M | -24.98M | -21.99M | -33.09M |
Capital Expenditures | -16K | -27K | -27K | -254K | -303K | -351K | -362K | -201K | -213K | -308K | -302K | -473K | -435K | -577K | -883K | -1.19M | -1.26M | -1.08M |
Cash Acquisitions | 8K | 8K | 8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8K | n/a | -4.49M | -14.31M | -27.18M | -64.11M | -68.91M | -71.28M | -95.82M | -75.64M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7M | 9.01M | 11.5M | 59.01M | 66.21M | 83.4M | 96.01M | 69M | 66.9M | 61.09M | 65.99M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -180K | 1.97M | 1.82M | 1.82M | 1.88M | 6.06M | 6.19M | 6.13M | 6.03M | -24.31M | -21.06M |
Investing Cash Flow | -8K | -19K | -19K | -254K | -303K | -351K | -362K | 6.62M | 8.75M | 11.02M | 54.04M | 51.3M | 55.52M | 31.18M | -998K | -5.87M | -36.28M | -11.02M |
Debt Repayment | -9.96M | -5.98M | -2.59M | -1.1M | 43.24M | 43.42M | 44.08M | 355K | -87.5M | -87.5M | -87.5M | -43.76M | -6K | -5K | 4.97M | 4.97M | 4.97M | 4.97M |
Common Stock Repurchased | n/a | n/a | n/a | -1K | -1K | -1K | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.3M | 690K | 690K | -616K | -616K | -3K | -24K | 43.73M | 43.73M | 43.73M | 43.73M | -17K | 28K | 269K | 526K | 971K | 926K | 595K |
Financial Cash Flow | 30.82M | 34.33M | 37.73M | -1.73M | 42.72M | 43.27M | 74.21M | -13.26M | -74.16M | -74.07M | -104.37M | -16.87M | 21K | 263K | 33.65M | 34.09M | 34.05M | 33.72M |
Net Cash Flow | -16.53M | -19.34M | -23.22M | -61.35M | -23.21M | -11.01M | 35.27M | 51.84M | 9.71M | 9.54M | 18.52M | 12.03M | 20.72M | 6.31M | 5.07M | 3.24M | -24.23M | -10.38M |
Free Cash Flow | -47.36M | -53.68M | -60.95M | -59.85M | -66.15M | -54.51M | -39.16M | -29.23M | -12.6M | -15.21M | -18.95M | -22.87M | -35.25M | -25.71M | -28.46M | -26.17M | -23.25M | -34.17M |